These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4799509)

  • 21. [Transplacental permeability of vanadium and its age-related distribution by organs].
    Ordzhonikize EK; Roshchin AV; Kazimov MA; Bogomazov MIa; Prilutskaia LL
    Gig Tr Prof Zabol; 1978 Jun; (6):34-8. PubMed ID: 669374
    [No Abstract]   [Full Text] [Related]  

  • 22. Transplacental in vivo/in vitro chemical carcinogenesis by AF-2, furylfuramide, in golden hamster cells [proceedings].
    Nishi Y; Inui N; Kondo M
    Mutat Res; 1976 Oct; 38(5):338-9. PubMed ID: 972626
    [No Abstract]   [Full Text] [Related]  

  • 23. [Embryogenesis and early postnatal development of rats following transplacental sex hormone administration].
    Ird EA; Smirnova IO
    Biull Eksp Biol Med; 1980 Nov; 90(11):607-9. PubMed ID: 6256027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of excess vitamin A on the development of rat embryos in culture.
    Morriss GM; Steele CE
    J Embryol Exp Morphol; 1974 Oct; 32(2):505-14. PubMed ID: 4477994
    [No Abstract]   [Full Text] [Related]  

  • 25. [Passing of antibiotics through the placenta and their effect on embryonic and fetal development].
    Kiriushchenkov AP
    Akush Ginekol (Mosk); 1975 Sep; (9):1-6. PubMed ID: 1232849
    [No Abstract]   [Full Text] [Related]  

  • 26. Transplacental passage of pesticides into human embryo.
    Rosival L; Szokolay A; Grunt J
    Czech Med; 1983; 6(1):1-7. PubMed ID: 6191931
    [No Abstract]   [Full Text] [Related]  

  • 27. [Transplacental passage of the antiviral agent, bonafton].
    Kurnaeva VP; Proĭnova VA; Ponomareva VL; Aĭzina NL; Shmeleva EV
    Farmakol Toksikol; 1980; 43(2):208-12. PubMed ID: 7002601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the embrotoxic properties of the repellent diethyltoluamide].
    Gleĭberman SE; Volkova AP; Nikolaev GM; Zhukova EV
    Farmakol Toksikol; 1975; 38(2):202-5. PubMed ID: 1227890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of bonaphthone on embryogenesis in white rats and mice].
    Proïnova VA; Pershin GN; Shashkina LF; Golubeva MI
    Farmakol Toksikol; 1978; 41(1):109-14. PubMed ID: 624381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymic differentiation of rat yolk-sac placenta as affected by a teratogenic agent.
    Johnson EM; Spinuzzi R
    J Embryol Exp Morphol; 1966 Oct; 16(2):271-88. PubMed ID: 5971990
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cultivation of rat embryos in vitro by New's method in pharmacoembryology].
    Persianinov LS; Kiriushchenkov AP; Skosyreva AM
    Arkh Anat Gistol Embriol; 1974 Apr; 66(4):93-7. PubMed ID: 4460987
    [No Abstract]   [Full Text] [Related]  

  • 32. [Embryotoxic and teratogenic effects of mercury].
    Sikorski R; Paszkowski T
    Wiad Lek; 1984 Oct; 37(20):1617-23. PubMed ID: 6396963
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of orally applied formaldehyde on the embryogenesis and enzyme activity of subcellular structures in pregnant rats].
    Merkurjewa RW; Rachmanin JA; Burmantowa NP; Jankelewitsch IB; Dolinskaja SI
    Z Gesamte Hyg; 1983 Feb; 29(2):66-8. PubMed ID: 6679443
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental study of the transplacental transport of gentamycin].
    Nichoga LA; Voropaeva SD
    Akush Ginekol (Mosk); 1982 Jan; (1):50-1. PubMed ID: 7065369
    [No Abstract]   [Full Text] [Related]  

  • 35. [Special features of the rat embryogenesis in experimental lesions of the maternal lungs caused by hydrogen sulfide].
    Pavlova TE; Sal'nikova LS; Sheveleva GA
    Akush Ginekol (Mosk); 1977 Jun; (6):69-71. PubMed ID: 879452
    [No Abstract]   [Full Text] [Related]  

  • 36. [Agar diffusion method for a determination of fucidin in body fluids and tissues].
    Koroleva VG
    Antibiotiki; 1971; 16(8):727-9. PubMed ID: 5003151
    [No Abstract]   [Full Text] [Related]  

  • 37. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embryo/fetal toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in rats and rabbits.
    Ozolins TR; Gupta U
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):161-70. PubMed ID: 15282737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanism of transplacental penetration of N-nitrosodimethylamine into rat and mouse fetuses].
    Shendrikova IA; Aleksandrov VA; Dikun PP; Napalkov NP
    Farmakol Toksikol; 1983; 46(6):53-7. PubMed ID: 6653759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.